他克莫司
- Tacrolimus
-
他克莫司与环孢霉素治疗单纯性V型狼疮性肾炎的疗效比较
Comparative Study on the Therapeutic Effect between Tacrolimus and Cyclosporine in the Treatment of Pure Class V Lupus Nephritis
-
他克莫司与环孢素A比较治疗胰肾联合移植术后排斥反应的Meta分析
Tacrolimus versus Cyclosporine A for Simultaneous Pancreas-Kidney Transplant Recipients : A Meta-Analysis
-
ELISA法监测肾移植患者他克莫司全血浓度448例次
Monitoring of tacrolimus in 448 samples from renal transplant recipients by ELISA
-
他克莫司对转化生长因子-β诱导的肾小管上皮细胞转分化的抑制作用及对核因子-κB活性的影响
Effects of FK506 on transdifferentiation and NF - κ B activity of human tubular cells induced by TGF - β in vitro
-
他克莫司用于中国肾移植患者远期疗效的Meta分析
Long-term curative effect of tacrolimus in kidney transplantation patients in China : Meta-analysis
-
基于SVR的他克莫司血药浓度的预测模型
Tacrolimus Blood Concentration Forecast Model based on Support Vector Regression
-
他克莫司及5-Fu对肝癌细胞株增殖及其血管内皮细胞生长因子表达的影响
Effect of Tacrolimus Associated with 5-Fu on the Proliferation and the Expression of VEGF in Hepatocellular Carcinoma
-
他克莫司对炎症反应血清TNF-α、IL-1β含量的影响
Effect of Tacrolimus on Serum TNF - α and IL-1 β Levels during Inflammatory Reactions Induced in Mice and Rats
-
小剂量他克莫司预处理有效减轻I八损伤引起的SOD、MDA、LDH改变。
Low-dose FK506 preconditioning significantly reduced changes of SOD , MDA , LDH activities in intestinal mucosa associated with I / R injury .
-
环孢素+霉酚酸酯+强的松治疗组MS发病率高于他克莫司+霉酚酸酯+强的松治疗组,但差异无显著意义。
There was no difference between the incidence of MS in recipients treated with cyclosporine + MMF + prednisone and recipients treated with tacrolimus + MMF + prednisone .
-
目的:比较0.1%,0.03%他克莫司软膏与赋形剂治疗中、重度特应性皮炎(AD)的疗效和安全性。
Objective : To observe the clinical efficacy and safety of 0.1 % and 0.03 % tacrolimus cream in topical treatment of moderate to severe atopic dermatitis in adults .
-
结论他克莫司对体外培养的大鼠胰岛细胞有直接的损害作用,而Bcl-2能防治这种损害作用。
Conclusion Tacrolimus may directly damage to isolated rat islet cells and the expression of Bcl-2 can protect the cells from the damage of immunosuppressive drugs .
-
他克莫司(Tacrolimus)是一种广泛使用的免疫抑制剂,可局部使用抑制角膜移植术后的排斥反应。
Tacrolimus is one kind of widely used immunosuppressive agents , topical anti-rejection of corneal transplantation .
-
他克莫司(Tacrolimus,FK506)是一种强效的免疫抑制剂,因在水中溶解度低限制了其应用。
Tacrolimus ( FK506 ) is a potent immunosuppressant , but its poor solubility restricted its application .
-
方法将36例斑块状银屑病患者随机分治疗组和对照组各18例,治疗组采用0.1%他克莫司软膏和尿素软膏外涂,bid,共治疗4周;
Methods Thirty-six patients were randomized equally into 2 groups . The treatment group was treated topically with 0.1 % tacrolimus ointment plus 10 % urea ointment , bid .
-
联合应用NB-UVB与他克莫司对小鼠他克莫司透皮吸收及IL-10表达的影响
Effects of NB-UVB Combined with Tacrolimus on Percutaneous Penetration of Tacrolimus and Expression of IL-10 in Mice
-
目的:评价他克莫司(FK506)用于肾移植患者免疫抑制治疗的效果与安全性。
OBJECTIVE : To objectively evaluate the immunosuppressive effect and safety of tacrolimus ( FK506 ) in renal transplant recipients .
-
目的比较高危肾移植患者术后应用环孢素A(CsA)和他克莫司(FK506)的疗效和安全性。
Objective To compare the efficiency and safety of CsA and FK506 used in the renal transplantation recipients with high risk factors .
-
新型免疫抑制剂效果强,副作用小,已倍受重视,例如他克莫司(FK506)、雷帕霉素(rapamycin,RAP)都是研发的热点。
The neotype immunity inhibitors had the better effect of treatment , and little side effect , such as FK506 , rapamycin .
-
6例患者停用免疫抑制治疗,3例患者将他克莫司(FK506)或CsA降低到最低有效血药浓度。
Patients were deprived of immunosuppression treatment and 3 patients received tacrolimus and cyclosporine with their blood levels kept in the low therapeutic range .
-
他克莫司对UVA照射后HaCaT细胞增殖的影响
The Inhibitory Effect of Tacrolimus on the Proliferation of Keratinocytes Irradiated by UVA
-
目的探讨低血药浓度FK506(他克莫司)在肝移植方面的效果以及并发症的处理。
Objective To discuss the immunosuppressive treatment of low blood concentration in FK506 in the aspects of liver transplanting and treatment of complications .
-
目的分析肝移植后需用环孢素A(CsA)替换他克莫司(FK506)的原因和结果。
Objective To analyze the causes and outcome of conversion from tacrolimus ( FK506 ) to cyclosporine-A ( CsA ) in recipients after liver transplantation .
-
目的比较他克莫司(FK506)与环孢素A(CsA)预防肾移植术后排斥反应的效果和安全性。
Objective To compare the effect and safety of taerolimus ( FK506 ) and cyclosporin ( CsA ) in the prevention of renal transplant rejection .
-
目的研究他克莫司(FK506)和来氟米特(Lef)对异种胰岛移植后急性排斥反应的抑制作用。
Objective To assess the preventive effects of FK506 and Leflunomide ( Lef ) on islet xenograft acute rejection in rat-to-mouse models .
-
结果低剂量和高剂量的他克莫司都能诱导胰岛细胞凋亡,减少胰岛素分泌,Bcl-2能抑制凋亡,改善胰岛素分泌。
Results Low and high concentrations of tacrolimus induced the apoptosis of islet cells and decreased insulin secretion . The Bcl-2 inhibited the apoptosis of islet cells induced by tacrolimus and improved the insulin secretion .
-
Caco-2细胞转运实验证明了五酯胶囊可通过抑制P-gp对他克莫司的外排作用而使他克莫司口服生物利用度增加。
The transport of tacrolimus using Caco-2 cell monolayers demonstrated that its bioavailability was enhanced when Wuzhi capsule inhibited the P-gp efflux pump . 5 .
-
HPLC-MS/MS法与MEIA法在监测器官移植患者他克莫司全血浓度中的比较
Comparison on two methods of HPLC-MS / MS and MEIA in monitoring the tacrolimus concentrations for organ transplantation patients
-
目的:探讨他克莫司(FK506)预处理对炎症反应血清肿瘤坏死因子(TNFα)、白细胞介素1β(IL1β)含量的影响。
Objective : To study the effect of tarcrolimus ( FK506 ) on serum TNF - α and IL-1 β levels during inflammatory reactions induced in mice and rats .
-
目的观察他克莫司(FK506)对肠黏膜屏障的损伤以及谷氨酰胺(Gln)对该损伤的保护作用,并探讨其作用机制。
OBJECTIVE To investigate the damage of tacrolimus ( FK506 ) to small intestinal mucosa barrier and the protective effect of glutamine ( Gln ) for the damage .